Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Health Catalyst (HCAT) Shares Outstanding (2018 - 2026)

Health Catalyst filings provide 9 years of Shares Outstanding readings, the most recent being $73.9 million for Q1 2026.

  • On a quarterly basis, Shares Outstanding rose 6.29% to $73.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $73.9 million, a 6.29% increase, with the full-year FY2025 number at $72.1 million, up 12.63% from a year prior.
  • Shares Outstanding hit $73.9 million in Q1 2026 for Health Catalyst, up from $72.1 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $73.9 million in Q1 2026 to a low of $53.5 million in Q1 2022.
  • Median Shares Outstanding over the past 5 years was $59.0 million (2024), compared with a mean of $61.5 million.
  • Biggest five-year swings in Shares Outstanding: grew 20.64% in 2022 and later grew 4.25% in 2023.
  • Health Catalyst's Shares Outstanding stood at $55.3 million in 2022, then rose by 5.49% to $58.3 million in 2023, then rose by 9.86% to $64.0 million in 2024, then grew by 12.63% to $72.1 million in 2025, then increased by 2.39% to $73.9 million in 2026.
  • The last three reported values for Shares Outstanding were $73.9 million (Q1 2026), $72.1 million (Q4 2025), and $70.7 million (Q3 2025) per Business Quant data.